SciELO - Scientific Electronic Library Online

 
vol.35 número1Apendicite do Coto Apendicular: um Desafio DiagnósticoEmbolia Pulmonar por Cimento Ósseo índice de autoresíndice de assuntosPesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Acta Radiológica Portuguesa

versão impressa ISSN 2183-1351

Acta Radiol Port vol.35 no.1 Lisboa abr. 2023  Epub 30-Abr-2023

https://doi.org/10.25748/arp.26396 

Imagens de Interesse

Bladder Rhabdomyosarcoma in an Infant with Schimmelpenning Syndrome

Rabdomiossarcoma de Bexiga em Recém-Nascido com Síndrome de Schimmelpenning

1Irmandade da Santa Casa de Misericórdia de Santos, Santos, Brasil

2Clínica MegaImagem, Santos, Brasil

3WEBIMAGEM Telerradiologia, São Paulo, Brasil


Abstract

Bladder tumors occur more frequently between the fifth and seventh decades of life - they are rare before 40 years of age. Rhabdomyosarcoma is a rare embryonic tumor originating from skeletal muscle tissue. The tumor can appear anywhere in the body, even where there is no skeletal muscle. When located in the genitourinary tract, it can present with hematuria and anuria. The nevus sebaceous of Jadassohn (NSJ) is a congenital hamartoma of cutaneous structures, with epithelial and adnexal origin, present in approximately 0.3% of newborns, and may contain any component of the skin, including sebaceous and apocrine glands or hair. When associated with syndromic features such as mental retardation, central nervous system abnormalities, cardiovascular defects such as the cardiac arrhythmia reported in this case, ocular or skeletal abnormalities, it is called linear sebaceous nevus syndrome, or Schimmelpenning syndrome.

Key words: Infant newborn; Nevus sebaceous of jadassohn; X-ray computed tomography; Magnetic resonance imaging.

Resumo

Os tumores de bexiga ocorrem com mais frequência entre a quinta e a sétima década de vida, sendo raros antes dos 40 anos de idade. O rabdomiossarcoma é um tumor embrionário raro originado do tecido muscular esquelético que pode aparecer em qualquer parte do corpo, mesmo onde não há músculo esquelético. Quando localizado no trato geniturinário, pode apresentar-se com hematúria e anúria. O nevo sebáceo de Jadassohn (NSJ) é um hamartoma congénito de estruturas cutâneas, de origem epitelial e anexial, presente em aproximadamente 0,3% dos recém-nascidos, podendo conter qualquer componente da pele, incluindo glândulas sebáceas e apócrinas ou cabelos. Quando está associado a características sindrómicas, como atraso mental, anomalias do sistema nervoso central, defeitos cardiovasculares (como a arritmia cardíaca relatada neste caso), anomalias oculares ou esqueléticas, é denominado síndrome do nevo sebáceo linear ou síndrome de Schimmelpenning.

Palavras-chave: Recém-nascido; Nevo sebáceo de jadassohn; Tomografia computadorizada por raios X; Imagem por ressonância magnética.

Bladder tumors occur more frequently between the fifth and seventh decades of life - they are rare before 40 years of age. Rhabdomyosarcoma is a rare embryonic tumor originating from skeletal muscle tissue.1) When located in the genitourinary tract, it can present with hematuria and anuria.1) Being a tumor of embryonic origin, it is more common in children and very rare in adults: 85% occur in children and adolescents.1

Although most musculoskeletal tumors occur in the chest, arms, and legs, rhabdomyosarcomas often appear elsewhere in the body. The most common site of involvement is the head and neck (30% to 40%), followed by the urinary and reproductive systems (20% to 25%). However, the tumor can appear anywhere in the body, even where there is no skeletal muscle.1 When located in the genitourinary tract, it can present with hematuria and anuria.1

In most cases, bladder tumors are asymptomatic. The clinical condition, when apparent, progresses with hematuria, intermittent or persistent without apparent causes, with an approximate average of 25% of patients presenting macroscopic and 9% microscopic hematuria.1,2 Other manifestations include flank pain, irritative and obstructive symptoms, such as increased voiding frequency, voiding urgency, retention, dysuria, nocturia, hydronephrosis, and changes in renal function. Signs and symptoms vary according to the location and extent of the tumor mass.1,2

Diagnosis consists of vesical visualization through cystoscopy and abdominal and pelvic evaluation through imaging exams, followed by a biopsy or resection.2 It is a very aggressive tumor, which usually requires surgical treatment, with partial resections and even complete removal of a large part of the lower genitourinary tract.2

The presentation of the tumor on ultrasound demonstrates a heterogeneous lesion with sonolucent areas, corresponding to sites of hemorrhage or necrosis. On CT, we should look for an image consistent with a heterogeneous, infiltrative attenuation mass, usually with imprecise borders. On the other hand, MRI reveals a low signal on T1-weighted images and a high signal on T2-weighted images, allowing for a better assessment than ultrasound and CT of the local extension of the tumor and the involvement of adjacent structures.

The nevus sebaceous of Jadassohn (NSJ) is a congenital hamartoma of cutaneous structures, with the epithelial and adnexal origin, present in approximately 0.3% of newborns, and may contain any component of the skin, including sebaceous and apocrine glands or hair.1 Most often seen in the head and neck region, it presents as a well-demarcated yellowish alopecia plaque.1 In our case, the nevus was confirmed with a biopsy and pathological examination of the cephalic lesion. The nature of secondary tumors that arise in sebaceous nevus and the risk of malignant neoplasm are controversial issues.1

When a Jadassohn sebaceous nevus is associated with syndromic features such as mental retardation, central nervous system abnormalities, cardiovascular defects such as the cardiac arrhythmia reported in this case, ocular or skeletal abnormalities, it is called linear sebaceous nevus syndrome, or Schimmelpenning syndrome.1 The etiology is still unknown, but recent studies point to a possible link with the mother´s positivity for the human papillomavirus or mutations in the patched gene (PTCH).2) Luo et al. noticed a novel mutation in the HRAS gene (c.38G>T; p.Gly13Val) was noticed in a mosaic state in NS and rhabdomyosarcoma, which could be a connection between these entities.3

We report a male infant aged four months and 13 days old, weighting 4.3 kg, with a history of diarrhea for ten days, low formula acceptance, and prostration. He had not urinated for four days and had started incoercible vomiting. He was born at 34 weeks, remaining in the neonatal intensive care unit for 48 days due to a previous diagnosis of fetal cardiac arrhythmia.

On physical examination, the baby was hypoactive/reactive, pale 2+/4+ and dehydrated 1+/4+. The abdomen was globular with reduced air-fluid sounds, distended, painful on diffuse palpation, with a thickened spermatic cord, there was a bilateral hydrocele.

He also had large, hairless, yellowish-brown plaques on the scalp (Figure 1), which were already present at birth according to his mother. Histopathological examination of these lesions on the scalp revealed hyperkeratosis, acanthosis, and hyperplasia of the sebaceous glands, compatible with nevus sebaceous of Jadassohn. Karyotype evaluation showed: karyotype 46, XY, presence of variant15CENH+ (increase in centromeric heterochromatin in one of chromosomes 15). Renal function deteriorated - urea (323 mg/ml) and creatinine (7.20 mg/ml).

Figure 1: Hairless, yellowish-brown plaques on the scalp of a four-month-old infant. Histopathological examination revealed hyperkeratosis, acanthosis, and hyperplasia of the sebaceous glands, compatible with Jadassohn sebaceous nevus. 

Urethrocystography was performed (Figure 2), which demonstrated a defect in the bladder contrast. Ultrasonography and computed tomography (CT) showed a bladder mass measuring approximately 6.5 cm (Figure 2), later confirmed by magnetic resonance imaging (MRI) (Figure 3).

Figure 2: A: urethrocystography showing a defect in the bladder contrast (white arrow). B: Ultrasonography showing expansive and infiltrative lesion affecting the bladder wall (grey arrow). C: contrast-enhanced CT in the coronal section demonstrating bilateral ureterohydronephrosis (white arrows). D: contrast-enhanced CT in the axial section showing an expansive and infiltrative lesion affecting the lateral wall and the vesical floor, invading the ureteral meatus (black arrows), causing bilateral ureterohydronephrosis. 

Figure 3: A: MRI in the axial section of the sequence T1 showing diffuse thickening of the bladder walls (white arrows). B: MRI in the axial section of the sequence T2 showing an expansive lesion affecting the bladder wall (black arrow). 

The bladder tumor was excised - the anatomopathological analysis diagnosed botryoid-type embryonal rhabdomyosarcoma with compromised margins - and the patient is currently undergoing chemotherapy. Bladder ultrasonography and CT scan were normal after the surgical procedure.

References

1. Jaqueti G, Requena L, Sánchez Yus E. Trichoblastoma is the most common neoplasm developed in nevus sebaceus of Jadassohn: a clinicopathologic study of a series of 155 cases. Am J Dermatopathol. 2000;22:108-18. [ Links ]

2. Parekh DJ, Bochner BH, Dalbagni G. Superficial and muscle-invasive bladder cancer; principles of management for outcomes assessments. J Clin Oncol. 2006;24:5519-27. [ Links ]

3. Luo Q, Zhang Q, Shen J, Guan W, Li M, Zhang J, Tan Z. Expanding mutational spectrum of HRAS by a patient with Schimmelpenning-Feuerstein-Mims syndrome. J Dermatol. 2021;48:1273-6. [ Links ]

Ethical disclosures

Financing Support: This work has not received any contribution, grant or scholarship.

Received: February 06, 2022; Accepted: April 24, 2022

Address Márcio Luís Duarte, WEBIMAGEM Telerradiologia, Av. Marquês de São Vicente, São Paulo, SP, Brasil, e-mail: marcioluisduarte@gmail.com

Conflicts of interest: The authors have no conflicts of interest to declare.

Confidentiality of data: The authors declare that they have followed the protocols of their work center on the publication of data from patients.

Protection of human and animal subjects: The authors declare that the procedures followed were in accordance with the regulations of the relevant clinical research ethics committee and with those of the Code of Ethics of the World Medical Association (Declaration of Helsinki).

© Author(s) (or their employer(s)) and ARP 2023. Re-use permitted under CC BY-NC. No commercial re-use.

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License